Abstract
The presence of cell-free fetal DNA in the plasma of pregnant women has opened up the possibility of noninvasive prenatal diagnosis. With the advances in molecular techniques of microfluidics and massive parallel sequencing, an increasing number of fetal genetic diseases/conditions can be noninvasively detected using maternal plasma DNA analysis. Remarkably, it has recently been shown that the genome-wide genetic map of an unborn fetus can be constructed through extensive sequencing of maternal plasma DNA. In this chapter the different qualitative and quantitative approaches and related methodology for the analysis of fetal DNA in maternal plasma are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lo YMD, Corbetta N, Chamberlain PF et al (1997) Presence of fetal DNA in maternal plasma and serum. Lancet 350:485–487
Birch L, English CA, O'Donoghue K et al (2005) Accurate and robust quantification of circulating fetal and total DNA in maternal plasma from 5 to 41 weeks of gestation. Clin Chem 51:312–320
Scheffer PG, van der Schoot CE, Page-Christiaens GC et al (2010) Reliability of fetal sex determination using maternal plasma. Obstet Gynecol 115:117–126
Wright CF, Burton H (2009) The use of cell-free fetal nucleic acids in maternal blood for non-invasive prenatal diagnosis. Hum Reprod Update 15:139–151
Rijnders RJ, van der Schoot CE, Bossers B et al (2001) Fetal sex determination from maternal plasma in pregnancies at risk for congenital adrenal hyperplasia. Obstet Gynecol 98:374–378
Lo YMD, Hjelm NM, Fidler C et al (1998) Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 339:1734–1738
Finning K, Martin P, Summers J et al (2008) Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. BMJ 336:816–818
Muller SP, Bartels I, Stein W et al (2008) The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible. Transfusion 48:2292–2301
Scheffer PG, van der Schoot CE, Page-Christiaens GC et al (2011) Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience. Int J Obstet Gynaecol 118:1340–1348
Van der Schoot CE, Soussan AA, Koelewijn J et al (2006) Non-invasive antenatal RHD typing. Transfus Clin Biol 13:53–57
Daniels G, Finning K, Martin P et al (2009) Noninvasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects. Prenat Diagn 29:101–107
Finning K, Martin P, Daniels G (2004) A clinical service in the UK to predict fetal Rh (Rhesus) D blood group using free fetal DNA in maternal plasma. Ann N Y Acad Sci 1022:119–123
Amicucci P, Gennarelli M, Novelli G et al (2000) Prenatal diagnosis of myotonic dystrophy using fetal DNA obtained from maternal plasma. Clin Chem 46:301–302
Gonzalez-Gonzalez MC, Trujillo MJ, Rodriguez de Alba M et al (2003) Huntington disease-unaffected fetus diagnosed from maternal plasma using QF-PCR. Prenat Diagn 23:232–234
Saito H, Sekizawa A, Morimoto T et al (2000) Prenatal DNA diagnosis of a single-gene disorder from maternal plasma [letter] [in process citation]. Lancet 356:1170
Brojer E, Zupanska B, Guz K et al (2005) Noninvasive determination of fetal RHD status by examination of cell-free DNA in maternal plasma. Transfusion 45:1473–1480
Zhou L, Thorson JA, Nugent C et al (2005) Noninvasive prenatal RHD genotyping by real-time polymerase chain reaction using plasma from D-negative pregnant women. Am J Obstet Gynecol 193:1966–1971
Chim SSC, Tong YK, Chiu RWK et al (2005) Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc Natl Acad Sci USA 102:14753–14758
Lui YY, Chik KW, Chiu RWK et al (2002) Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. Clin Chem 48:421–427
Chan KCA, Ding C, Gerovassili A et al (2006) Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem 52:2211–2218
Li Y, Kazzaz JA, Kellner LH et al (2010) Incorporation of fetal DNA detection assay in a noninvasive RhD diagnostic test. Prenat Diagn 30:1010–1012
Zejskova L, Jancuskova T, Kotlabova K et al (2010) Feasibility of fetal-derived hypermethylated RASSF1A sequence quantification in maternal plasma – next step toward reliable non-invasive prenatal diagnostics. Exp Mol Pathol 89:241–247
Lo YMD, Tein MS, Lau TK et al (1998) Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 62:768–775
Lun FMF, Chiu RWK, Chan KCA et al (2008) Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma. Clin Chem 54:1664–1672
Lo YMD, Zhang J, Leung TN et al (1999) Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 64:218–224
Al-Yatama MK, Mustafa AS, Ali S et al (2001) Detection of Y chromosome-specific DNA in the plasma and urine of pregnant women using nested polymerase chain reaction. Prenat Diagn 21:399–402
Botezatu I, Serdyuk O, Potapova G et al (2000) Genetic analysis of DNA excreted in urine: a new approach for detecting specific genomic DNA sequences from cells dying in an organism. Clin Chem 46:1078–1084
Illanes S, Denbow ML, Smith RP et al (2006) Detection of cell-free fetal DNA in maternal urine. Prenat Diagn 26:1216–1218
Li Y, Zhong XY, Kang A et al (2003) Inability to detect cell free fetal DNA in the urine of normal pregnant women nor in those affected by preeclampsia associated HELLP syndrome. J Soc Gynecol Investig 10:503–508
Illanes S, Parra M, Serra R et al (2009) Increased free fetal DNA levels in early pregnancy plasma of women who subsequently develop preeclampsia and intrauterine growth restriction. Prenat Diagn 29:1118–1122
Lo YMD, Leung TN, Tein MS et al (1999) Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem 45:184–188
Tsui DW, Chan KC, Chim SS et al (2007) Quantitative aberrations of hypermethylated RASSF1A gene sequences in maternal plasma in pre-eclampsia. Prenat Diagn 27:1212–1218
Lo YMD, Lau TK, Zhang J et al (1999) Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21. Clin Chem 45:1747–1751
Zhong XY, Burk MR, Troeger C et al (2000) Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses. Prenat Diagn 20:795–798
Zhong XY, Laivuori H, Livingston JC et al (2001) Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia. Am J Obstet Gynecol 184:414–419
Leung TN, Zhang J, Lau TK et al (2001) Increased maternal plasma fetal DNA concentrations in women who eventually develop preeclampsia. Clin Chem 47:137–139
Sifakis S, Zaravinos A, Maiz N et al (2009) First-trimester maternal plasma cell-free fetal DNA and preeclampsia. Am J Obstet Gynecol 201(472):e471–e477
Lau TW, Leung TN, Chan LYS et al (2002) Fetal DNA clearance from maternal plasma is impaired in preeclampsia. Clin Chem 48:2141–2146
Gerovassili A, Garner C, Nicolaides KH et al (2007) Free fetal DNA in maternal circulation: a potential prognostic marker for chromosomal abnormalities? Prenat Diagn 27:104–110
Lun FMF, Tsui NBY, Chan KCA et al (2008) Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma. Proc Natl Acad Sci USA 105:19920–19925
Vogelstein B, Kinzler KW (1999) Digital PCR. Proc Natl Acad Sci USA 96:9236–9241
Tsui NBY, Chim SSC, Chiu RWK et al (2004) Systematic micro-array based identification of placental mRNA in maternal plasma: towards non-invasive prenatal gene expression profiling. J Med Genet 41:461–467
Lo YMD, Tsui NBY, Chiu RWK et al (2007) Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med 13:218–223
Tsui NB, Akolekar R, Chiu RW et al (2010) Synergy of total PLAC4 RNA concentration and measurement of the RNA single-nucleotide polymorphism allelic ratio for the noninvasive prenatal detection of trisomy 21. Clin Chem 56:73–81
Lo YMD, Lun FMF, Chan KCA et al (2007) Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proc Natl Acad Sci USA 104:13116–13121
Tong YK, Ding C, Chiu RWK et al (2006) Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: theoretical and empirical considerations. Clin Chem 52:2194–2202
Tong YK, Jin S, Chiu RWK et al (2010) Noninvasive prenatal detection of trisomy 21 by an epigenetic-genetic chromosome-dosage approach. Clin Chem 56:90–98
Chiu RWK, Chan KCA, Gao Y et al (2008) Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci USA 105:20458–20463
Fan HC, Blumenfeld YJ, Chitkara U et al (2008) Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci USA 105:16266–16271
Chiu RWK, Akolekar R, Zheng YW et al (2011) Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 342:c7401
Ehrich M, Deciu C, Zwiefelhofer T et al (2011) Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol 204(205):e201–e211
Sehnert AJ, Rhees B, Comstock D et al (2011) Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood. Clin Chem 57:1042–1049
Chen EZ, Chiu RW, Sun H et al (2011) Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing. PLoS One 6:e21791
Palomaki GE, Deciu C, Kloza EM et al (2012) DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med 14:296–305
Lun FM, Jin YY, Sun H et al (2011) Noninvasive prenatal diagnosis of a case of Down syndrome due to robertsonian translocation by massively parallel sequencing of maternal plasma DNA. Clin Chem 57:917–919
Lo YMD, Chan KCA, Sun H et al (2010) Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med 2:61ra91
Chan KCA, Zhang J, Hui AB et al (2004) Size distributions of maternal and fetal DNA in maternal plasma. Clin Chem 50:88–92
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Chan, K.C.A. (2012). Clinical Applications of the Latest Molecular Diagnostics in Noninvasive Prenatal Diagnosis. In: L.S. Tang, N., Poon, T. (eds) Chemical Diagnostics. Topics in Current Chemistry, vol 336. Springer, Berlin, Heidelberg. https://doi.org/10.1007/128_2012_352
Download citation
DOI: https://doi.org/10.1007/128_2012_352
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-39941-1
Online ISBN: 978-3-642-39942-8
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)